U.S. federal trademark · Serial No. 77965593
Pharmaceutical products, namely, activate cranial nerve cells- improve ability of memory and learning keep away from diseases caused by cranial nerve degeneration including senile dementia for alzheimer's disease patients, forgetful patients in climacteric period , kennedy's syndrome patients , elders , dementia patients , stroke patients , financial professionals who are always using mathematics , children in growth and development, students facing examination pressure, melancholia patients, children suffering from infantile autism , children suffering from adhd, sensory integration disorder patients of all ages
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.